Tumor Cell Conversion Antigenic

Tumor cell conversion is a process in which cancer cells change through mutations and acquire new properties that help them spread and grow in the body. This process can occur under the influence of various factors, including genetic changes, chemical influences and the body's immune system. During antigenic conversion of tumor cells, cancer tissue acquires new properties due to changes in antigens that bind foreign substances. This term refers to qualitative rearrangements of the genome of tumor tissue. This concept reflects multiple approaches to cancer treatment, including oncologic chemotherapy and immunotherapy.

Currently, the mechanisms of antigen conversion therapy are being actively studied, due to which tumor metastasis is usually triggered and the body itself begins to actively fight the resulting tumor growth. This is usually due to the reaction of immune cells. This reaction itself is carried out through the process of entangling cancer cells with our immune cells and then destroying them. But introducing these new antigens to other sites can cause an immune response that gets out of control, thus enslaving the immune system. Therefore, it becomes important to properly remove toxic products and “clean out”